| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 13 May 2026 | 12 May 2026 |
| Inter alia, to consider and approve:- 1. TO CONSIDER AND APPROVE THE RESOLUTION FOR EXTENTION OF TIME FOR UTILIZATION OF NET ISSUE PROCEEDS AND COMPLETION OF PROJECT AS STATED IN PROSPECTUS 2. TO CONSIDER AND APPROVE THE RESOLUTION FOR UTILIZATION OF FUNDS UNDER GENERAL CORPORATE PURPOSE (GCP) FOR WORKING CAPITAL REQUIREMENTS AS WELL In compliance with Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that, the Board of Directors in its meeting held on May 13, 2026, have inter-alia, considered and approved the following matters: a. To consider and approve the resolution for extension of time for utilization of net issue proceeds and completion of project as stated in the prospectus. b. To consider and approve the resolution for utilization of funds under General Corporate Purpose (GCP) for working capital requirements as well. c. Any other item- Discussion regarding faults in the Companys hardware and software systems which resulted in unexpected shutdown of certain systems for a temporary period and were subsequently restored/recovered. (As per BSE Announcement dated on: 13.05.2026) | ||
| Board Meeting | 9 Mar 2026 | 28 Feb 2026 |
| Modern Diagnostic & Research Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/03/2026 inter alia to consider and approve a. To consider and approve change in equipment specification from SPECT to SPECT-CT at Sector 40 Gurugram b. To consider and approve change of vendor for execution of building electrical and air-conditioning works for Diagnostic Centre and certain laboratories outside Delhi c.To consider and approve change in location for opening of Laboratory within Delhi d. Opening of Bank account and loan transfer to Axis Bank Gurugram e. To Consider and approve Authorization for execution of Legal Tender Lease/Rent and other miscellaneous documents on behalf of the Company and also to do any kind of Sale/Purchase or to enter into any contract on behalf of the Company. In compliance with Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that, the Board of Directors in its meeting held on March 09, 2026, have inter-alia, considered and approved the following matters: 1. To approve change in equipment specification from SPECT to SPECT-CT at Sector-40 Gurugram. 2. To approve change of vendor for execution of building, electrical and air-conditioning works for Diagnostic Centre and certain laboratories outside Delhi. 3. To approve change in location for opening of laboratory within Delhi. 4. Opening of bank account and loan transfer to Axis Bank, Gurugram. 5. Authorization for execution of legal, tender, lease/rent and other miscellaneous documents on behalf of the Company and also to do any kind of sale/purchase or to enter into any contract on behalf of the Company. 6. Other item was proposed by the chairperson as Opening of bank account with Standard Chartered Bank. (As per BSE announcement dated on :09.03.2026) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.